Rituximab-responsive Guillain-Barré syndrome following allogeneic hematopoietic SCT

Bone Marrow Transplantation

Volumn 42, Issue 1, 2008, Pages 71-72

  Ostronoff, F ^a   Perales, M A ^b   Stubblefield, M D ^b   Hsu, K C ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUSULFAN; CD3 ANTIGEN; CD34 ANTIGEN; CYTARABINE; FLUDARABINE; GLUCOSE; IDARUBICIN; IMMUNOGLOBULIN; MELPHALAN; PROTEIN; RITUXIMAB; STEROID; THYMOCYTE ANTIBODY;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; ARTIFICIAL VENTILATION; BACKACHE; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL EXAMINATION; DIARRHEA; DYSAUTONOMIA; ELECTROMYOGRAPHY; EPSTEIN BARR VIRUS; GRAFT VERSUS HOST REACTION; GRAM STAINING; GUILLAIN BARRE SYNDROME; HLA MATCHING; HUMAN; MALE; MOTOR DYSFUNCTION; MUSCLE STRENGTH; MYELODYSPLASTIC SYNDROME; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCYTOPENIA; PARESTHESIA; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUADRIPLEGIA; RESPIRATORY FAILURE; TREATMENT OUTCOME; VIREMIA;

ANTIBODIES, MONOCLONAL; GUILLAIN-BARRE SYNDROME; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOLOGIC FACTORS; MALE; MIDDLE AGED; TRANSPLANTATION, HOMOLOGOUS; VIREMIA;

EID: 48949116739     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2008.81     Document Type: Article

References (10)

1. Wen PY, Alyea EP, Simon D, Herbst RS, Soiffer RJ, Antin JH. Guillain-Barré syndrome following allogeneic bone marrow transplantation. Neurology 1997; 49: 1711-1714.
2. Rodriguez V, Kuehnle I, Heslop HE, Khan S, Krance RA. Guillain-Barré syndrome after allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2002; 29: 515-517.
3. Hughes RA, Comblath DR. Guillain-Barré syndrome. Lancet 2005; 366: 1653-1666.
4. Amato AA, Barohn RJ, Sahenk Z, Tutschka PJ, Mendell JR. Polyneuropathy complicating bone marrow and solid organ transplantation. Neurology 1993; 43: 1513-1518.
5. Bashir RM, Bierman P, McComb R. Inflammatory peripheral neuropathy following high dose chemotherapy and autologous bone marrow transplantation. Bone Marrow Transplant 1992; 10: 305-306.
6. Gross TG, Steinbuch M. DeFor T, Shapiro RS, McGlave P, Ramsay NK et al. B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: Risk factors, treatment and outcome. Bone Marrow Transplant 1999; 23: 251-258.
7. Nobile-Orazio E. Treatment of dys-immune neuropathies. J Neurol 2005; 252: 385-395.
8. Patriarca F, Skert C, Sperotto A, Zaja F. Falleti E, Mestroni R et al The development of autoantibodies after allogeneic stem cell transplantation is related with chronic graft-vs-host disease and immune recovery. Exp Hematol 2006; 34: 389-396.
9. Patchell RA. Neurological complications of organ transplantation. Ann Neurol 1994; 36: 688-703.
10. Cutler C, Miklos D, Kim HT, Treister N, Woo SB, Bienfang D et al. Rituximab for steroid-refractory chronic graft-versus-host disease. Blood 2006; 108: 756-762.